We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

51 hedge funds and large institutions have $138M invested in Axcella Health Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 4

280% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 5

174% more capital invested

Capital invested by funds: $50.4M → $138M (+$87.7M)

65% more funds holding

Funds holding: 3151 (+20)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
51
Holders Change
+20
Holders Change %
+64.52%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
24
Increased
19
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$69.4M +$18.6M +152,000 +43%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$29.7M +$10.8M +88,352 +70%
HP
3
Harbourvest Partners
Massachusetts
$15.5M +$7.73M +63,158 +128%
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.24M +$3.69M +30,175 +390%
AG
5
Artal Group
Luxembourg
$4.98M +$1.47M +12,000 +50%
BlackRock
6
BlackRock
New York
$4.21M +$2.06M +16,804 +123%
MIM
7
Monashee Investment Management
Massachusetts
$1.24M +$1.1M +9,000 New
Renaissance Technologies
8
Renaissance Technologies
New York
$989K +$875K +7,152 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$871K +$567K +4,636 +278%
State Street
10
State Street
Massachusetts
$784K +$127K +1,042 +23%
Northern Trust
11
Northern Trust
Illinois
$764K +$382K +3,121 +130%
Marshall Wace
12
Marshall Wace
United Kingdom
$660K +$583K +4,767 New
EI
13
EAM Investors
California
$502K +$444K +3,628 New
Two Sigma Investments
14
Two Sigma Investments
New York
$384K +$340K +2,780 New
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$353K +$312K +2,554 New
N
16
Nuveen
North Carolina
$276K +$182K +1,484 +289%
Millennium Management
17
Millennium Management
New York
$271K +$240K +1,960 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$220K +$195K +1,590 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$202K +$60.2K +492 +51%
Charles Schwab
20
Charles Schwab
California
$173K +$69.5K +568 +84%
Tudor Investment Corp
21
Tudor Investment Corp
Connecticut
$148K +$131K +1,068 New
Squarepoint
22
Squarepoint
New York
$141K +$125K +1,022 New
Goldman Sachs
23
Goldman Sachs
New York
$138K +$122K +998 New
VF
24
Virtu Financial
New York
$120K +$107K +871 New
Wells Fargo
25
Wells Fargo
California
$98K +$27.9K +228 +48%

AXLA Hedge Fund Activity: Q2 2020 in Review

51 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2020, worth a combined $138M — up 174% from $50.4M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AXLA positions and 4 closed out — a net gain of 20 holders — while 19 added to existing stakes and 5 trimmed.

The largest buyer was Flagship Pioneering, adding an estimated $18.6M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $263K sold.

  • 51 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2020, up from 31 in Q1 2020.
  • Funds reported $138M of Axcella Health Inc. Common Stock stock for Q2 2020, up 174% quarter-over-quarter.
  • 24 funds opened new Axcella Health Inc. Common Stock positions in Q2 2020 and 4 closed out, a net change of +20 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q2 2020 was Flagship Pioneering, an estimated $18.6M added.
  • The largest Axcella Health Inc. Common Stock seller in Q2 2020 was Alyeska Investment Group, an estimated $263K sold.

Based on aggregated 13F filings for Q2 2020.